• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • MONTAIR 4 mg, 5 mg Chewable Tablets
    / CTS


    Active Ingredient

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Chewable Tablets

    30


    Dosage

    Adults and adolescents over 15 years old: For treatment of asthma and/or seasonal allergic rhinitis, take two 5 mg chewable tablets once per day.
    Children 6-14 years old, for treatment of asthma or seasonal allergic rhinitis: One 5 mg chewable tablet once per day.
    Children 2-5 years old for treatment of asthma or seasonal allergic rhinitis:
    One 4 mg chewable tablet once per day.
    For treatment of asthma, the drug should be taken once per day, in the evening.
    For treatment of seasonal allergic rhinitis , the drug should be taken once per day.
    The tablet should be chewed before swallowing, regardless of meals.
    This drug is  not intended for babies and children under 2 years old. Please refer to the license holder for further details.


    Indications

    Indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction.
    The drug is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma.
    This drug  and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability.
    Indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.


    Contra-Indications

    Hypersensitivity to an active substance or any of its excipients.


    Manufacturer
    CTS Chemical Industries Ltd
    CLOSE